Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | 393,40 € | 456,30 € | 15,99 % |
| Neurocrine Bioscience | 49 | 0 | 2 | 0 | 133,55 € | 148,09 € | 10,89 % |
| Ionis Pharmaceuticals Inc. | 48 | 1 | 2 | 0 | 70,26 € | 71,43 € | 1,66 % |
| Insulet Corp. | 47 | 0 | 17 | 0 | 261,60 € | 315,97 € | 20,78 % |
| Exelixis Inc. | 40 | 0 | 4 | 0 | 38,09 € | 40,48 € | 6,27 % |
| Tenet Healthcare | 40 | 0 | 3 | 0 | 181,00 € | 190,72 € | 5,37 % |
| Jazz Pharmaceuticals plc | 39 | 0 | 5 | 0 | 145,80 € | 169,26 € | 16,09 % |
| Merit Medical Systems | 31 | 0 | 2 | 0 | ? | 95,59 € | 34,63 % |
| PTC Therapeutics Inc. | 32 | 2 | 1 | 1 | ? | 69,08 € | 5,47 % |
| Acadia Pharmaceuticals | 27 | 1 | 4 | 0 | 23,57 € | 27,38 € | 16,16 % |
| United Therapeutics | 24 | 1 | 1 | 0 | 415,90 € | 480,20 € | 15,46 % |
| Ultragenyx Pharmaceutical Inc. | 21 | 0 | 3 | 0 | ? | 78,31 € | 150,99 % |
| Icon plc | 21 | 0 | 0 | 0 | 159,60 € | 203,65 € | 27,60 % |
| Charles River Labs Intl | 19 | 0 | 4 | 0 | 158,25 € | 165,88 € | 4,82 % |
| Halozyme Therapeutics Inc. | 21 | 2 | 3 | 1 | 54,40 € | 67,75 € | 24,54 % |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | 52,76 € | 64,41 € | 22,09 % |
| Masimo Corp. | 17 | 0 | 4 | 0 | 121,70 € | 174,29 € | 43,21 % |
| Repligen Corp. | 18 | 1 | 0 | 0 | 141,70 € | 158,80 € | 12,06 % |
| Alkermes plc | 17 | 0 | 4 | 0 | ? | 38,70 € | 54,81 % |
| Bio-Techne Corp. | 17 | 0 | 3 | 0 | 53,00 € | 60,82 € | 14,76 % |
| Haemonetics Corp. | 17 | 1 | 3 | 0 | 72,00 € | 76,78 € | 6,64 % |
| Iovance Biotherapeutics Inc. | 17 | 2 | 0 | 0 | 1,89 € | 15,72 € | 733,88 % |
| LivaNova plc | 15 | 0 | 3 | 0 | ? | 57,19 € | 4,94 % |
| Bruker Corp. | 15 | 0 | 2 | 0 | 41,24 € | 45,57 € | 10,49 % |
| West Pharmaceutical Services Inc. | 14 | 0 | 0 | 0 | 240,60 € | 299,29 € | 24,39 % |